Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI South Africa ETF (EZA) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

iShares MSCI South Africa ETFTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI South Africa ETF vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? iShares MSCI South Africa ETF trades at $63.8 (market cap $455.34M), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 13.3× iShares MSCI South Africa ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI South Africa ETF for 70 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

EZAIOVA
Market Cap
$455.34M$6.04B
Volume
148,69214,805,993
Sector
Broad Market / FactorHealth
52-Week High
$81.60$14.82
52-Week Low
$60.43$1.81
Typical Hold Time
70 Days0 Days
Enterprise Value
—$5.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI South Africa ETF

EZA trades at $63.8, up 2.42% today, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The stock faces resistance near $64 and support at $61. Recent news highlights a brief price surge above the 50-day moving average in September but ongoing macroeconomic pressures from South Africa's exposure to commodities and financials.

The outlook remains cautious due to global reflation and high capital costs weighing on EZA's holdings. Risks include commodity price volatility and interest rate sensitivity, while potential upside hinges on stabilization in South African markets. Investors should weigh the ETF's concentrated exposures against broader emerging market uncertainties.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EZA

No sentiment data available yet.

IOVA
51% Buy49% Sell
Avg holding period · 0 Days

About iShares MSCI South Africa ETF

EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.

Read more on EZA →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →